{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:27:53Z","timestamp":1794338873036,"version":"4.9.0"},"reference-count":14,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.3201\/eid3209.260790","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:57:05Z","timestamp":1787068625000},"source":"Crossref","is-referenced-by-count":0,"title":["Case Report and Retrospective Review of\n                    <i>Acanthamoeba<\/i>\n                    Encephalitis and Chronic Lymphocytic Leukemia, United States"],"prefix":"10.3201","volume":"32","author":[{"given":"Michele","family":"Persico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C.","family":"Haston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Imada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Kasten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cederic","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3209.260790-202608181156-R1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1574-695X.2007.00232.x","article-title":"Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea.","volume":"50","author":"Visvesvara","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"key":"key-10.3201\/eid3209.260790-202608181156-R2","doi-asserted-by":"publisher","first-page":"ofac682","DOI":"10.1093\/ofid\/ofac682","article-title":"The epidemiology and clinical features of non-keratitis Acanthamoeba infections in the United States, 1956\u20132020.","volume":"10","author":"Haston","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"key-10.3201\/eid3209.260790-202608181156-R3","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1200\/JCO.23.02738","article-title":"Chronic lymphocytic leukemia: time to care for the survivors.","volume":"42","author":"Fedele","year":"2024","journal-title":"J Clin Oncol"},{"key":"key-10.3201\/eid3209.260790-202608181156-R4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1182\/asheducation-2007.1.332","article-title":"Management of infectious complications in patients with chronic lymphocytic leukemia.","volume":"2007","author":"Morrison","year":"2007","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"key-10.3201\/eid3209.260790-202608181156-R5","first-page":"374","article-title":"Infections in chronic lymphocytic leukemia. Analysis of incidence as a function of length of follow-up.","volume":"78","author":"Molica","year":"1993","journal-title":"Haematologica"},{"key":"key-10.3201\/eid3209.260790-202608181156-R6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s40265-014-0178-8","article-title":"Ibrutinib: first global approval.","volume":"74","author":"Cameron","year":"2014","journal-title":"Drugs"},{"key":"key-10.3201\/eid3209.260790-202608181156-R7","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.3389\/fimmu.2020.02158","article-title":"BTK inhibition impairs the innate response against fungal infection in patients with chronic lymphocytic leukemia.","volume":"11","author":"Fiorcari","year":"2020","journal-title":"Front Immunol"},{"key":"key-10.3201\/eid3209.260790-202608181156-R8","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1182\/blood-2018-11-846808","article-title":"How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemia.","volume":"133","author":"Stephens","year":"2019","journal-title":"Blood"},{"key":"key-10.3201\/eid3209.260790-202608181156-R9","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/cid\/ciy175","article-title":"Serious infections in patients receiving ibrutinib for treatment of lymphoid cancer.","volume":"67","author":"Varughese","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid3209.260790-202608181156-R10","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1128\/JCM.43.6.3003-3006.2005","article-title":"Inability to make a premortem diagnosis of Acanthamoeba species infection in a patient with fatal granulomatous amebic encephalitis.","volume":"43","author":"Bloch","year":"2005","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid3209.260790-202608181156-R11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1756-3305-5-6","article-title":"Biology and pathogenesis of Acanthamoeba.","volume":"5","author":"Siddiqui","year":"2012","journal-title":"Parasit Vectors"},{"key":"key-10.3201\/eid3209.260790-202608181156-R12","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1002\/cncr.25292","article-title":"Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia.","volume":"116","author":"Shanafelt","year":"2010","journal-title":"Cancer"},{"key":"key-10.3201\/eid3209.260790-202608181156-R13","doi-asserted-by":"publisher","first-page":"ofaa025","DOI":"10.1093\/ofid\/ofaa025","article-title":"Fulminant Acanthamoeba castellanii encephalitis in an ibrutinib-treated patient.","volume":"7","author":"Crothers","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"key-10.3201\/eid3209.260790-202608181156-R14","doi-asserted-by":"publisher","first-page":"6514604","DOI":"10.1155\/2018\/6514604","article-title":"Amebic encephalitis in a patient with chronic lymphocytic leukemia on ibrutinib therapy.","volume":"2018","author":"Voshtina","year":"2018","journal-title":"Case Rep Hematol"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/32\/9\/26-0790_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:16:52Z","timestamp":1794338212000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/32\/9\/26-0790_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3209.260790","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}